PINL:GRPOF - Post by User
Comment by
TripleEmon May 23, 2018 2:24am
173 Views
Post# 28067715
RE:RE:RE:RE:Shorts are dropping like flies...
RE:RE:RE:RE:Shorts are dropping like flies...gkmackdadzzz1 wrote: What big pharmacompanies? How about being definitive I your weak argument
1-
Tetra Natural Health a division of Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF) and - Namaste Technologies Inc. (“Namaste” or the “Company”) (TSX-V:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed a Supply Agreement ( the “Supply Agreement”) for the sale and distribution of Rx Princeps™ the medicinal cannabis brand of Tetra Natural Health, a division of Tetra Bio-Pharma (“Tetra Bio-Pharma”)(TSX-V:TBP) (OTCQB:TBPMF), whereby Namaste will purchase Rx Princeps™ from Tetra Natural Health which will be sold through Namaste’s wholly owned subsidiary Access to Cannabis for Medical Purposes (“ACMPR”) medical cannabis “sales-only” facility, Cannmart Inc. (“Cannmart”). Read more at https://www.stockhouse.com/news/press-releases/2018/05/17/tetra-natural-health-signs-a-supply-agreement-with-namaste-technologies-for-the#1CHv9U4RISIux14K.99 2-
“We are honored to partner with Azevedos, a company established in 1775, rich in tradition, and a major player in the Portuguese pharmaceutical market. This Partnership deal provides Tetra with its foray into the European market.” stated Dr. Guy Chamberland M.Sc., Ph.D., Interim CEO and Chief Scientific Officer. Read more at https://www.stockhouse.com/news/press-releases/2018/05/04/tetra-biopharma-signs-second-commercialization-deal-with-azevedos-industria#icKCtBgjuI2elbhW. 3-
The finalization of the term sheet follows Tetra's September 20th, 2017 Letter of Intent for a co-development and distribution partnership with the same privately held company in the specialty healthcare market. The company has a pan-Canadian distribution network that reaches up to 7000 specialized healthcare professionals. Through their distribution channel, they have access to more than 3000 specialized healthcare businesses in Canada and already work with a worldwide network of partners Read more at https://www.stockhouse.com/news/press-releases/2018/03/08/tetra-bio-pharma-signs-co-development-and-distribution-partnership-term-sheet#qWK5I3JoArrdi8cl.99 4-
Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria Read more at https://www.stockhouse.com/news/press-releases/2017/11/16/tetra-bio-pharma-inc-rx-princeps-tm-now-available-for-patients-through-licenced#13TPYsWTpjwQ8Fux.99 Tetra and Aphria will enter into a joint supply agreement, with Aphria supplying dried medical cannabis under its ACMPR license, and Tetra packaging the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001. Read more at https://www.stockhouse.com/news/press-releases/2017/04/19/tetra-bio-pharma-aphria-announce-plans-for-the-joint-distribution-of-dried#rblUtDJRKcPMzCKV.99
5-- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), announced today that the Company has signed a first binding term sheet for the marketing and distribution of PPP001 in Israel with Kamada Ltd., a leading pharmaceutical company. The signing of a Definitive Distribution Agreement is expected to follow shortly. PPP001 is being developed to be the first smokable cannabis product for advanced cancer pain available under prescription.
Read more at https://www.stockhouse.com/news/press-releases/2018/04/24/tetra-bio-pharma-signs-landmark-commercialization-term-sheet-for-its-lead#xLswM1WUPMDLSQCY.99 JMO, GLTA...
GO TETRA GO>>>